Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India (1) 'Zydus receives Final Approval from the USFDA for Levothyroxine Sodium for Injection' and (2) 'Zydus receives Final Approval from the USFDA for Doxepin Hydrochloride Capsules'.